Minerva Neurosciences (NERV) Non-Current Assets (2013 - 2026)

Minerva Neurosciences (NERV) posted Non-Current Assets of $14.9 million for Q1 2026, little changed on a QoQ basis from $14.9 million in Q4 2025, and little changed year-over-year from $14.9 million in Q1 2025.

Minerva Neurosciences (NERV) Non-Current Assets (2013 - 2026) Analysis & Trends

Minerva Neurosciences' Non-Current Assets history runs 14 years deep, the most recent figure standing at $14.9 million for Q1 2026.

  • Quarterly Non-Current Assets changed 0.32% year-over-year to $14.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59.7 million (changed 0.38% YoY) and the FY2025 annual result came in at $14.9 million, changed 0.04% from the prior year.
  • Non-Current Assets was $14.9 million for Q1 2026 at Minerva Neurosciences, roughly flat from $14.9 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $15.1 million in Q3 2025 and bottomed at $14.9 million in Q4 2025.
  • A 5-year average of $14.9 million and a median of $14.9 million in 2023 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Non-Current Assets slumped 50.5% — and 2025, when it climbed 1.32%.
  • Minerva Neurosciences' Non-Current Assets stood at $14.9 million in 2022, then declined by 0.21% to $14.9 million in 2023, then slipped by 0.15% to $14.9 million in 2024, then slipped by 0.04% to $14.9 million in 2025, then gained by 0.34% to $14.9 million in 2026.
  • Business Quant data shows NERV's Non-Current Assets at $14.9 million in Q1 2026, $14.9 million in Q4 2025, and $15.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Minerva Neurosciences 195.10 Mn 195.10 Mn - 14.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 14.92 Mn
Dec 31, 2025 14.87 Mn
Sep 30, 2025 15.07 Mn
Jun 30, 2025 14.87 Mn
Mar 31, 2025 14.87 Mn
Dec 31, 2024 14.87 Mn
Sep 30, 2024 14.88 Mn
Jun 30, 2024 14.88 Mn
Mar 31, 2024 14.89 Mn
Dec 31, 2023 14.90 Mn
Sep 30, 2023 14.91 Mn
Jun 30, 2023 14.91 Mn
Mar 31, 2023 14.92 Mn
Dec 31, 2022 14.93 Mn
Sep 30, 2022 14.92 Mn
Jun 30, 2022 14.92 Mn
Mar 31, 2022 14.92 Mn
Dec 31, 2021 14.92 Mn
Sep 30, 2021 30.12 Mn
Jun 30, 2021 30.10 Mn